fbpx | Page 39 | NDARC - National Drug and Alcohol Research Centre

Search Results - The search found 1169 results

Year: 2016

Journal article

Copeland, J., & Alperstein, D. (2016). Cannabis: use, harms, disorder, and interventions. Australian Clinical Psychologist, 2(1), 20103. Retrieved from http://www.acpa.org.au/.

Year: 2016

Journal article

Copeland, J., & Pokorski, I. (2016). Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review. Substance Abuse and Rehabilitation, 7, 41-53. doi: 10.2147/SAR.S89857

Year: 2016

Journal article

Copeland, J., Gates, P., & Pokorski, I. (2016). A narrative review of psychological cannabis use treatments with and without pharmaceutical adjunct. Current Pharmaceutical Design, 22, 1-12. doi: 10.2174/1381612822666160831094811.

Year: 2016

Journal article

Courtney, R. J., Clare, P., Boland, V., Matire, K. A., Bonevski, B., Hall, W., Siahpush, M., Borland, R., Doran, C. M., West, R., Farrrell, M., & Mattick, R. P. (2017). Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers. Addictive Behaviors, 64, 13-20. doi: 10.1016/j.addbeh.2016.07.019

Year: 2016

Book chapter

Crome, E., Baillie, A., Teesson, M., Kay-Lambkin, F., & Deady, M. (2016). Implementation of evidence-based interventions: Barriers and opportunities. In R. G. Menzies, M. Kyrios & N. Kazantzis (Eds.), Innovations and future directions in the behavioural and cognitive therapies (pp. 277-281). Samford Valley, Qld: Australian Academic Press.

Year: 2016

Journal article

Currier, D., Pirkis, J., Carlin, J., Degenhardt, L., Dharmage, S. C., Giles-Corti, B., Gordon, I., Gurrin, L., Hocking, J., Kavanagh, A., Keogh, L. A., Koelmeyer, R., LaMontagne, A. D., Schlichthorst, M., Patton, G., Sanci, L., Spittal, M. J., Studdert, D. M., Williams, J., & English, D. R. (2016). The Australian longitudinal study on male health-methods. BMC Public Health, 16 (Supplement 3), 3698. doi: 10.1186/s12889-016-3698-1

Year: 2016

Journal article

Cysique, L. A., Dermody, N., Carr, A., Brew, B. J., & Teesson, M. (2016). The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults. Journal of Neurovirology, 22(1), 56-65. doi: 10.1007/s13365-015-0368-5

Year: 2016

Journal article

Darke, S. (2016). Addiction classics: Editorial note. Addiction, 111(11), 1899. doi: 10.1111/add.13516

Year: 2016

Journal article

Darke, S. (2016). Heroin overdose: Addiction classics. Addiction, 111(11), 2060-2063. doi: 10.1111/add.13516

Year: 2016

Journal article

Darke, S. (2016). Psychosocial interventions for mental and substance use disorders: a framework for establishing evidence-based standards MARY JANE ENGLAND, ADRIENNE STITH BUTLER & MONICA L. GONZALEZ (EDITORS); COMMITTEE ON DEVELOPING EVIDENCE-BASED STANDARDS FOR PSYCHOSOCIAL INTERVENTIONS FOR MENTAL DISORDERS Washington, DC, USA: National Academies Press, 2015 ISBN: 978-0-309-31694-1, 176 pp. Paperback. Price: US$48.00 (or available free online): critique. Drug and Alcohol Review, 35(4), 503. doi: 10.1111/dar.12373

Year: 2016

Journal article

Darke, S., & Duflou, J. (2016). Response to Ruan and colleagues concerning ‘The toxicology of heroin-related death: estimating survival times’: letter to the editor. Addiction, 111(12), 2262. doi: 10.1111/add.13587

Year: 2016

Journal article

Darke, S., & Duflou, J. (2016). The toxicology of heroin-related death: estimating survival times. Addiction, 111, 1607-1613. doi:10.1111/add.13429

Year: 2016

Journal article

Darke, S., & Farrell, M. (2016). Commentary on Singh et al "Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized control trials". Still searching for the answer. Addiction, 111(8), 1347. doi: 10.1111/add.13369

Year: 2016

Journal article

Darke, S., & Farrell, M. (2016). Response to commentaries on ‘Which medications are suitable for agonist drug maintenance’. Addiction, 111(5), 781-782. doi: 10.1111/add.13359

Year: 2016

Journal article

Darke, S., & Farrell, M. (2016). The twenty-first century opioid epidemic: what is happening and what can be done? The Addictions Newsletter, Spring, 18-20. Retrieved from http://www.apa.org/divisions/div50/Newsletters/tan-spring-2016.pdf.

Year: 2016

Journal article

Darke, S., & Farrell, M. (2016). Which medications are suitable for agonist drug maintenance? Addiction, 111(5), 767-774. doi: 10.1111/add.13158

Year: 2016

Journal article

Darke, S., Marel, C., Mills, K. L., Ross, J., Slade, T., & Teesson, M. (2016). Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015. Drug and Alcohol Dependence, 162, 206-210. doi: 10.1016/j.drugalcdep.2016.03.010

Year: 2016

Journal article

Darke, S., Slade, T., Ross, J., Marel, C., Mills, K. L., & Teesson, M. (2016). Patterns and correlates of injecting among heroin users: A 11-year follow-up of the Australian Treatment Outcome Study cohort. Addictive Disorders and Their Treatment, 15(3), 111-119. doi: 10.1097/ADT.0000000000000082

Year: 2016

Journal article

Davies, S. J. C., Pearson, R. M., Stapinski, L., Bould, H., Christmas, D. M., Button, K. S., Skapinakis, P., Lewis, G., & Evans, J. (2016). Symptoms of generalized anxiety disorder but not panic disorder at age 15 years increase the risk of depression at 18 years in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort study. Psychological Medicine, 46(1), 73-85. doi: 10.1017/S003329171500149X

Year: 2016

Journal article

Day, C. A., Shanahan, M., Wand, H., Topp, L., Haber, P. S., Rodgers, C., Deacon, R., Walsh, N., Kaldor, J., van Beek, I., Maher, L., & Hepatitis Acceptability Group Vaccine Incentives Trial Study, G. (2016). Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial. Journal of Clinical Virology, 74, 66-72. doi: 10.1016/j.jcv.2015.11.031

Year: 2016

Journal article

Deacon, R. M., Nielsen, S., Leung, S., Rivas, G., Cubitt, T., Monds, L. A., Ezard, N., Larance, B., & Lintzeris, N. (2016). Alprazolam use and related harm among opioid substitution treatment clients – 12 months follow up after regulatory rescheduling. International Journal of Drug Policy, 36, 104-111. doi: 10.1016/j.drugpo.2016.06.006

Year: 2016

Journal article

Deady, M., Mills, K. L., Teesson, M., & Kay-Lambkin, F. (2016). An online intervention for co-occurring depression and problematic alcohol use in young people: primary outcomes from a randomized controlled trial. Journal of Medical Internet Research, 18(3), e71. doi: 10.2196/jmir.5178

Year: 2016

Book chapter

Deady, M., Mills, K., Teesson, M., Kay-Lambin, F., Ross, J., Baillie, A., & Subotic, M. (2016). How do we best treat comorbid substance use and mental disorders? Evidence-based approaches to integrated treatment. In R. G. Menzies, M. Kyrios & N. Kazantzis (Eds.), Innovations and future directions in the behavioural and cognitive therapies (pp. 207-211). Samford Valley, Qld: Australian Academic Press.

Year: 2016

Book chapter

Degenhardt, L., & Hall, W. D. (2016). The impact of illicit drugs on public health. In H. H. Brownstein (Ed.), The Handbook of Drugs and Society (pp. 300-319). Hoboken, N.J.: John Wiley & Sons.

Year: 2016

Journal article

Degenhardt, L., Charlson, F., Stanaway, J., Larney, S., Alexander, L. T., Hickman, M., Cowie, B., Hall, W. D., Strang, J., Whiteford, H., & Vos, T. (2016). Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. The Lancet Infectious Diseases, 16(12), 1385-1398. doi: 10.1016/S1473-3099(16)30325-5